May 2018
We now cover digital breast tomosynthesis
Blue Cross Blue Shield of Michigan and Blue Care Network now cover digital breast tomosynthesis, or 3-D mammography, as a screening or diagnostic modality to assess and manage breast cancer for individuals meeting certain criteria, effective March 1, 2018.
Digital breast tomosynthesis may be considered when used in combination with digital screening mammography in high-risk individuals, or a qualified health care provider (ordering provider or radiologist) determines that it should be the primary mammographic study.
For the medical policy, see the billing chart in the April Record.
|